Delivery Order SPE2DB24D2011-SPE2DB25FBPUA

Award Date 1/14/25
Potential Completion Date 1/15/25
Potential Value $29K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,468.07 firm fixed-price delivery order is for Ozempic 0.25-0.5 mg/dose pens, with a completion date of January 22, 2025. This contract award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $19,051.59, is a delivery order for the supply of Ozempic 0.25-0.5 mg/dose pens. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,600.85 firm-fixed-price contract is for the supply of Ozempic 0.25-0.5 mg/dose pens, a diabetes medication. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $49,120.20, is a delivery order for the supply of Ozempic 0.25-0.5 mg/dose pens. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,898.26 firm-fixed-price delivery order is for the supply of Ozempic 0.25-0.5 mg/dose pens with a completion date of November 20, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,295.90 firm fixed-price delivery order is for the supply of Ozempic 0.25-0.5 mg/dose pens, a medication used for diabetes management. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,251.24 firm fixed price delivery order is for the supply of Ozempic 0.25-0.5 mg/dose pens with an ultimate completion date of November 8, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,831.88 firm fixed-price delivery order is for the supply of Ozempic 0.25-0.5 mg/dose pens. The contract has an ultimate completion date of December 12, 2024 and was awarded on December 11, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,190.97 firm fixed-price delivery order is for the supply of Ozempic 0.25-0.5 mg/dose pen 3 mL, a medication used for diabetes management. The contract has an ultimate completion date of December 4, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,842.08 fixed-price delivery order is for the supply of Ozempic 0.25-0.5 mg/dose pens with a completion date of July 22, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary...
  • SPE2DB24D2011
    Indefinite Delivery Contract
  • SPE2DB24D2011-SPE2DB25FBPUA
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $29,018.69 Firm Fixed Price Delivery Order is for the supply of Ozempic 0.25-0.5 mg/dose pens. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. This award demonstrates AmerisourceBergen's significant role in supplying critical medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, and other supplies, to various federal healthcare programs and institutions.

Generated 5/21/25, 10:30 AM